FIELD: medicine, in particular oncology.
SUBSTANCE: it is developed that for patients having initially decreased by 31 % membrane fluidity in lymphocyte protein-lipid contact zone, increased by 103 % protein embedment into lymphocyte lipid matrix, decreased by 5-6 times K-coefficient (ratio of chemoluminescence light-sum to ceruleoplasmin in blood plasma) in contrast with respective indexes for healthy women high effectiveness of chemotherapy is predicted. On the other hand for patients having initially normal structural and functional state of blood cell membranes and K-value alteration by 3-3.5 times or less law effectiveness of chemotherapy is predicted.
EFFECT: simplified and accelerated method for prognosis of individual patient sensitivity to chemotherapy.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING PATHOLOGICAL PROCESS GENERALIZATION IN THE CASES OF ONCOLOGICAL DISEASES | 2002 |
|
RU2241987C2 |
METHOD FOR PREDICTING BRAIN METASTATIC INJURIES GENERALIZATION | 2005 |
|
RU2300104C2 |
METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
METHOD FOR DETERMINATION OF MALIGNANT PROCESS ABUNDANCE | 2005 |
|
RU2289815C1 |
METHOD FOR TREATING OVARY CANCER | 1999 |
|
RU2163152C1 |
METHOD FOR TREATING MAMMALIAN GLAND CARCINOMA | 1998 |
|
RU2158588C2 |
METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
METHOD FOR PREDICTING INDIVIDUAL TUMOR SENSITIVITY TO CHEMOTHERAPY | 2000 |
|
RU2179725C2 |
METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
Authors
Dates
2005-06-20—Published
2003-03-03—Filed